Volume 8 -                   pbp 2026, 8 - : 0-0 | Back to browse issues page

XML Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Mendeley  
Zotero  
RefWorks

Ahmadi H, Khaksarian M. Medicinal Plants with Efficacy in Attention Deficit Hyperactivity Disorder (ADHD): Mechanistic Insights. pbp 2026; 8 (In press)
URL: http://pbp.medilam.ac.ir/article-1-352-en.html
1- Department of Psychiatry, Faculty of Medicine, Lorestan University of Medical Sciences, Khorramabad, Iran
2- Department of Physiology, Faculty of Medicine, Lorestan University of Medical Sciences, Khorramabad, Iran , mojkhaksar@yahoo.com
Abstract:   (32 Views)
Objective: From the perspective of traditional Iranian medicine, Attention Deficit Hyperactivity Disorder (ADHD) arises from an imbalance in bodily temperament and a weakening of cerebral and nervous faculties. This disturbance manifests as impaired concentration, heightened irritability, and impulsive hyperactivity. While conventional treatments offer symptomatic relief, their side effects in many patients highlight the growing need for complementary approaches. Utilizing medicinal plants to restore temperament balance and modulate neurological functions has emerged as a promising strategy in this regard. This review aims to identify key medicinal plants that alleviate ADHD symptoms and elucidate their underlying mechanisms of action.
Methods: This systematic review draws on classical texts and authentic sources of Iranian traditional medicine alongside contemporary scientific literature retrieved from databases including Google Scholar, SID, Magiran, PubMed, and Scopus. Keywords relevant to ADHD and herbal medicine guided the comprehensive literature search and analysis.
Results: Evidence points to several botanicals—such as Melissa officinalis (lemon balm), Valeriana officinalis (valerian), Crocus sativus (saffron), Passiflora incarnata (passionflower), Mentha species (mint), Matricaria chamomilla (chamomile), Lavandula angustifolia (lavender), Vaccinium species (blueberry), Rosmarinus officinalis (rosemary), Ocimum basilicum (basil), Camellia sinensis (green tea), Curcuma longa (turmeric), Boswellia serrata (frankincense), Mentha piperita (peppermint), Pinus species (pine), Centella asiatica (gotu kola), Linum usitatissimum (flaxseed), Avena sativa (oat), Tulipa species (garden tulip), and Hypericum perforatum (St. John’s wort)—as having notable efficacy in symptom modulation. These plants exert their beneficial effects by calming the nervous system, enhancing cognitive capacity, regulating the body's internal temperament—particularly heat and moisture balance—and modulating central nervous system activity. According to traditional medicine principles, these processes restore the equilibrium of bodily humors and vital forces, thereby creating a foundation for cognitive and behavioral recovery.
Conclusion: The existing body of evidence suggests that the judicious use of medicinal plants, grounded in the framework of Iranian traditional medicine, holds potential as a complementary therapeutic approach for managing ADHD. Nonetheless, establishing optimal dosing, confirming efficacy, and ensuring safety necessitate rigorous, large-scale, controlled clinical trials. The convergence of ancient wisdom with contemporary neuroscience and pharmacology promises to open new avenues for safe, natural, and effective treatment of this disorder.

 
     
Type of Study: Review/Systemtic review | Subject: Pharmacognosy
Received: 2025/09/11 | Accepted: 2025/09/14 | Published: 2026/01/20

References
1. Rahmani M, Mahvelati A, Farajinia AH, Shahyad S, Khaksarian M, Nooripour R, Hassanvandi S. Comparison of vitamin D, neurofeedback, and neurofeedback combined with vitamin D supplementation in children with attention-deficit/hyperactivity disorder. Arch Iran Med. 2022;25(5):285. doi: 10.34172/aim.2022.47.
2. Khaksarian M, Mirr I, Kordian S, Nooripour R, Ahangari N, Masjedi-Arani A. A comparison of methylphenidate (MPH) and combined methylphenidate with Crocus sativus (Saffron) in the treatment of children and adolescents with ADHD: a randomized, double-blind, parallel-group, clinical trial. Iran J Psychiatry Behav Sci. 2021 Jul 31. doi: 10.5812/ijpbs.108390.
3. Khaksarian M, Piri R, Sohrabifard MM. A comparison of the effect of neurofeedback on the improvement of the executive functions of individuals with ADHD and epilepsy. Yafteh. 2020;22(1).
4. Ghorbanzadeh V, Jafarpour A, Pirnia A, Pajouhi N, Khaksarian M, Veiskarami S, Nazari A. The role of vasopressin V1A and oxytocin OTR receptors in protective effects of arginine vasopressin against H2O2-induced oxidative stress in H9C2 cells. Arch Physiol Biochem. 2022;128(3):830-5. doi: 10.1080/13813455.2020.1729816.
5. Pour MR, Babaeenezhad E, Hadavand S, Elahian M, Alekasir A, Khaksarian M. Anti-inflammatory properties of chitosan hydrogel containing Satureja khuzestanica Jamzad essential oil on the animal model. Herb Med J. 2023;8(3):133-43. doi: 10.22087/hmj.v8i3.1017
6. Ahmadi M, Eidi A, Ahmadvand H, Khaksarian M, Sotoodehnejadnematalahi F. Effect of carvacrol on histological analysis and expression of genes involved in an animal model of multiple sclerosis. Mult Scler Relat Disord. 2023;70:104471. doi: 10.1016/j.msard.2022.104471.
7. Lange KW, Reichl S, Lange KM, Tucha L, Tucha O. The history of attention deficit hyperactivity disorder. ADHD Atten Defic Hyperact Disord. 2010;2(4):241-55. doi: 10.1007/s12402-010-0045-8.
8. Biederman J. Attention-deficit/hyperactivity disorder: a selective overview. Biol Psychiatry. 2005;57(11):1215-20. doi: 10.1016/j.biopsych.2004.10.020.
9. Yozwiak JA. Attention-deficit/hyperactivity disorder: epidemiology, assessment, and treatment among children, adolescents, and adults. 2010:87-95.
10. Millichap JG. Etiologic classification of attention-deficit/hyperactivity disorder. Pediatrics. 2008;121(2): 358-65.
11. Sharma A, Couture J. A review of the pathophysiology, etiology, and treatment of attention-deficit hyperactivity disorder (ADHD). Ann Pharmacother. 2014;48(2):209-25. doi: 10.1177/1060028013510699.
12. Sharma A, Couture J. A review of the pathophysiology, etiology, and treatment of attention-deficit hyperactivity disorder (ADHD). Ann Pharmacother. 2014;48(2):209-25.
13. Faraone SV, Biederman JO. Pathophysiology of attention deficit hyperactivity disorder. Neuropsychopharmacology: The fifth generation of progress. 2002:577-96.
14. Brown RT, Amler RW, Freeman WS, Perrin JM, Stein MT, Feldman HM, et al. Treatment of attention-deficit/hyperactivity disorder: overview of the evidence. Pediatrics. 2005;115(6): 749-57. doi: 10.1542/peds.2004-2560.
15. Dopheide JA, Pliszka SR. Attention-deficit-hyperactivity disorder: an update. Pharmacotherapy. 2009;29(6):656-79. doi: 10.1592/phco.29.6.656.
16. Chan E. The role of complementary and alternative medicine in attention-deficit hyperactivity disorder. J Dev Behav Pediatr. 2002;23:S37-45.
17. Sawni A. Attention-deficit/hyperactivity disorder and complementary/alternative medicine. Adolesc Med State Art Rev. 2008;19(2):313-26.
18. Bae HW, Lee SY, Kim SJ, Shin HK, Choi BT, Baek JU. Selecting effective herbal medicines for attention-deficit/hyperactivity disorder via text mining of Donguibogam. Evid Based Complement Alternat Med. 2019;2019:1798364. doi: 10.1155/2019/1798364.
19. Dutta T, Anand U, Mitra SS, Ghorai M, Jha NK, Shaikh NK, et al. Phytotherapy for attention deficit hyperactivity disorder (ADHD): a systematic review and meta-analysis. Front Pharmacol. 2022;13:827411.
20. Anheyer D, Lauche R, Schumann D, Dobos G, Cramer H. Herbal medicines in children with attention deficit hyperactivity disorder (ADHD): a systematic review. Complement Ther Med. 2017;30:14-23. doi: 10.1016/j.ctim.2016.11.004.
21. Avicenna. The Canon of Medicine (Al-Qanun fi al-Tibb). New York: AMS Press; 1973.
22. Aghili Khorasani MH. Makhzan al-Adwiyah (Treasury of Drugs). Tehran: Tehran University of Medical Sciences Press; 2009.
23. Chaghmini M. Qanunche-ye Chaghmini (The Small Canon of Chaghmini). Qom: Jalaleddin Publications; 2008.
24. Jorjani SE. Zakhireh Kharazmshahi (The Treasure of Kharazmshah). Tehran: Iranian Cultural Heritage Organization Press; 2001.
25. Ibn al-Baytar. Al-Jami li-Mufradat al-Adwiyah wa al-Aghdhiyah. Beirut: Dar al-Kotob al-Ilmiyah; 1992.
26. Qarshi I. Al-Asbab wa al-Alamat (Causes and Symptoms). Tehran: Academy of Medical Sciences of Iran; 2008.
27. Rhazes (Al-Razi). Kitab al-Hawi fi al-Tibb (The Comprehensive Book on Medicine). London: Routledge; 1996.
28. Tonkaboni M. Tohfat al-Mo’menin (Gift to the Believers). Tehran: Shahid Beheshti University of Medical Sciences Press; 2007.
29. Khorasani MA. Exir-e Azam (The Great Elixir). Tehran: Iranian Traditional Medicine Society Press; 2011.
30. Zargari A. Medicinal Plants. Vol. 1. Tehran: Tehran University Press; 1990.
31. Zargari A. Medicinal Plants. Vol. 2. Tehran: Tehran University Press; 1991.
32. Zargari A. Medicinal Plants. Vol. 3. Tehran: Tehran University Press; 1992.
33. Zargari A. Medicinal Plants. Vol. 4. Tehran: Tehran University Press; 1993.
34. Amin G. Popular Medicinal Plants of Iran. Tehran: Tehran University of Medical Sciences Press; 2005.
35. Mozaffarian V. Identification of Medicinal and Aromatic Plants of Iran. Tehran: Farhang Moaser; 2013.
36. Nadkarni KM. Indian Materia Medica. Vol. 1. Mumbai: Popular Prakashan; 1996.
37. Nadkarni KM. Indian Materia Medica. Vol. 2. Mumbai: Popular Prakashan; 1996.
38. Chopra RN, Nayar SL, Chopra IC. Glossary of Indian Medicinal Plants. New Delhi: CSIR; 1996.
39. Ghahraman A. Flora of Iran. Tehran: Research Institute of Forests and Rangelands; 2001.
40. Azizi M, Fathi Najafi M. Ethnobotany and Medicinal Plants of Iran. Mashhad: Ferdowsi University of Mashhad Press; 2015.
41. Martin AF, Rubin GJ, Rogers MB, Wessely S, Greenberg N, Hall CE, et al. The changing prevalence of ADHD? A systematic review. J Affect Disord. 2025;119427. doi: 10.1016/j.jad.2025.119427.
42. Kang M, Oh Y, Lee M, Jung J, Park JY. Research trends in traditional East Asian medicine for attention-deficit hyperactivity disorder. Korean J Acupunct. 2025;42(2):49-74. doi:10.14406/acu.2025.003
43. Mohammadi F, Abedi Z, Ahangarzadeh M. Iranian and herbal medicine methods in reducing anxiety before angiography: a systematic review. IBJ. 2024;28:203-3. doi:10.61186/ibj.25th-11th-IACRTIMSS
44. Hajiaghaee R, Akhondzadeh S. Herbal medicine in the treatment of attention-deficit/hyperactivity disorder. J Med Plants. 2011;10(39):1-6.
45. Akhondzadeh S. Attention-deficit/hyperactivity disorder and herbal medicine: an evidence-based approach. J Med Plants. 2018;17(65).
46. Noorazar SG, Mirzaei M, Kalejahi P. Iranian traditional medicine for treatment of attention deficit disorder with hyperactivity in children: a systematic review of randomized controlled trials. Iran J Public Health. 2024;53(2):280-92. doi: 10.18502/ijph.v53i2.14913.
47. Çankaya Ö. Herbal supplements used in the treatment of attention deficit and hyperactivity disorder. Anat J Pharm Sci. 2024;3(1):167-77.
48. Seydan SA, Abdollahpour A. Attention deficit hyperactivity disorder (ADHD) and the potential use of medicinal plants in its treatment. Second National Conf on the Application of Medicinal Plants in Lifestyle and Traditional Medicine, Mashhad; 2014. https://civilica.com/doc/386864
49. Varvani Farahani P, Ozturk C. Complementary and alternative medicine in treating children's diseases in Iran: a systematic review. J Pediatr Rev. 2024;12(4):329-42. http://dx.doi.org/10.32598/jpr.12.4.1136.4

Add your comments about this article : Your username or Email:
CAPTCHA

Send email to the article author


Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.